Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-acute Sequelae SARS-CoV-2 Infection (PASC)”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Not applicableStudy completedNCT06315894
What this trial is testing

Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study)

Who this might be right for
Post-COVID Condition
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 60
Early research (Phase 1)Study completedNCT05638620
What this trial is testing

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

Who this might be right for
Post Acute COVID-19 SyndromeLong COVIDLong Covid19+12 more
Jonathann Kuo, MD 20
Not applicableNot Yet RecruitingNCT06911476
What this trial is testing

From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19

Who this might be right for
PASC Post Acute Sequelae of COVID 19Long COVIDLong Covid-19+6 more
University Medical Center Groningen 60
Not applicableActive Not RecruitingNCT05167227
What this trial is testing

Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?

Who this might be right for
SARS-CoV-2 Acute Respiratory DiseaseMyalgic EncephalomyelitisChronic Fatigue Syndrome+2 more
Family Health Centers of San Diego 20
Not applicableStudy completedNCT06739668
What this trial is testing

Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

Who this might be right for
Post-Acute COVID-19 SyndromeCognitive Dysfunction
Icahn School of Medicine at Mount Sinai 30
Not applicableStudy completedNCT06052527
What this trial is testing

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

Who this might be right for
COVID-19Post-COVID-19 SyndromeInfluenza
Lizora LLC 27
Not applicableActive Not RecruitingNCT05092516
What this trial is testing

Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)

Who this might be right for
Dysexecutive SyndromePost-Acute Sequelae of COVID-19
Massachusetts General Hospital 31
Very early researchLooking for participantsNCT07076862
What this trial is testing

Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)

Who this might be right for
PASC Post Acute Sequelae of COVID-19
University of California, Davis 51
Not applicableLooking for participantsNCT06577467
What this trial is testing

Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection

Who this might be right for
PASC Post Acute Sequelae of COVID-19
National Institute of Neurological Disorders and Stroke (NINDS) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05690503
What this trial is testing

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

Who this might be right for
Post-acute Sequelae of COVID-19Depressive SymptomsCognitive Dysfunction
New York State Psychiatric Institute 12
Testing effectiveness (Phase 2)Study completedNCT05965726
What this trial is testing

RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

Who this might be right for
Long COVID-19Long COVID
Kanecia Obie Zimmerman 964
Not applicableLooking for participantsNCT06879925
What this trial is testing

Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Who this might be right for
PASC Post Acute Sequelae of COVID 19
POCHIWU 80
Not applicableStudy completedNCT06404060
What this trial is testing

RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)

Who this might be right for
Long COVIDLong Covid19Long Covid-19
Duke University 360
Large-scale testing (Phase 3)UnknownNCT05706454
What this trial is testing

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory Infection
KARE Biosciences 324
Early research (Phase 1)Looking for participantsNCT06920628
What this trial is testing

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Who this might be right for
Long COVIDPost Acute Sequelae of COVID-19
National Institute of Mental Health (NIMH) 60
Large-scale testing (Phase 3)Ended earlyNCT05946551
What this trial is testing

Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

Who this might be right for
COVID-19
Emory University 5
Large-scale testing (Phase 3)Enrolling By InvitationNCT07280572
What this trial is testing

RECLAIM Adaptive Platform Trial for PCC Treatments

Who this might be right for
Post COVID Condition
Janneke van de Wijgert 1,250
Testing effectiveness (Phase 2)Study completedNCT05152849
What this trial is testing

Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection

Who this might be right for
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
Axcella Health, Inc 41
Not applicableLooking for participantsNCT07278388
What this trial is testing

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

Who this might be right for
PASC Post Acute Sequelae of COVID 19Fatigue
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 200
Early research (Phase 1)Not Yet RecruitingNCT07388550
What this trial is testing

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

Who this might be right for
Post-Acute COVID-19 Syndrome
National Institute of Neurological Disorders and Stroke (NINDS) 15
Next Page